VIDO Market Share Analysis for March 2026

vido-intervac is a world leader in developing vaccines and technologies against infectious diseases.

Pets and Animals > Pet Food and Supplies

Domainvido.org

Year Founded1975

Employees51 - 200

Annual Revenue$10M - $15M

VIDO

VIDO (including company regionals)

vido.org

See more website traffic and engagement information

VIDO Revenue up to March 2026 is 10M - 15M

revenue generated by VIDO top domains

VIDO top domains revenue over 3 years

Revenue for VIDO top domains

vido.org10M - 15M

See more with Sales Intelligence

Total visits to VIDO's top domains

Understand VIDO market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

vido.org12.5K

See more with Sales Intelligence

Avg. visit duration in VIDO's top domains

Analyze VIDO engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

vido.org00:00:50

See more with Sales Intelligence

Avg. pageviews on VIDO's top domains

See how VIDO keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

vido.org2.46

See more with Sales Intelligence

VIDO top competitors by domain

Top similar sites in March 2026, ranked by their affinity

txbiomed.orgCompany NameTexas Biomedical Research InstituteEmployees201 - 500HQUnited States, Texas, San AntonioAnnual revenue$50M - $75MTotal visits11.9KScience and Education > Biology

Top technologies used by VIDO

These are the website technologies, by industry, used by VIDO top domains

Payment & Currencies (21)

PayPal

Advertising (4)

DoubleClick

Social (4)

Instagram

Conversion & Analytics (3)

Google Analytics

More Technologies

9

See all

News & Signals from VIDO

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPegasus Biotech Inc partnered with Vaccine and Infectious Disease Organization on Apr 2nd '26.CHARLOTTETOWN, PE, April 2, 2026 /PRNewswire-PRWeb/ - Pegasus Biotech Inc. is pleased to announce a strategic collaboration with the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) to advance the development and commercialization of Pegasus's BPE DNA platform for next-generation biologics.

NewsVaccine and Infectious Disease Organization receives financing of $2.5M.VIDO has secured more than $2.5 million through the Agriculture Development Fund (ADF), a federal and provincial government-supported program providing funding to key agricultural research.

NewsVaccine and Infectious Disease Organization attends event 2025 Conference.The University of Saskatchewan is hosting the International Society for Anthrozoology (ISAZ) 2025 Conference at their PAWSitive Connections Lab to focus on human-animal interconnectedness and relationships.